Stay updated on Adjuvant Nivolumab in Muscle-Invasive Bladder Cancer Clinical Trial

Sign up to get notified when there's something new on the Adjuvant Nivolumab in Muscle-Invasive Bladder Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Adjuvant Nivolumab in Muscle-Invasive Bladder Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The page footer revision/version was updated from **v3.5.2** to **v3.5.3**.
    Difference
    0.1%
    Check dated 2026-04-24T05:51:29.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:37:31.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Revision updated to v3.5.0, replacing the previous v3.4.3 revision.
    Difference
    0.1%
    Check dated 2026-03-19T04:52:50.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    Revision: v3.4.3 has been added and Revision: v3.4.2 has been removed.
    Difference
    0.1%
    Check dated 2026-03-12T00:27:27.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    The page now shows 'Results Submitted' in the Results section, replacing 'No Results Posted'. This indicates that trial results are in progress and awaiting posting.
    Difference
    0.1%
    Check dated 2026-02-18T16:25:51.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    Revision: v3.4.2 has been added, and the funding-lapse notice along with Revision: v3.4.1 have been removed.
    Difference
    0.5%
    Check dated 2026-02-11T11:00:31.000Z thumbnail image

Stay in the know with updates to Adjuvant Nivolumab in Muscle-Invasive Bladder Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Adjuvant Nivolumab in Muscle-Invasive Bladder Cancer Clinical Trial page.